Global Taste Modulators Market
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Taste Modulators Market by Type (Sweet Modulators, Salt Modulators, Fat Modulators), Application (Food, Beverages, Pharmaceutical), and Region (North America, Europe, Asia-Pacific, South America, RoW) - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
Taste Modulators market is projected to reach USD 2 billion by 2028 from USD 1.4 billion by 2023, at a CAGR of 7.4%
Salt modulators are poised to claim a substantial market share throughout the forecasted period due to compelling factors. A primary driver is the global health agenda focusing on reducing sodium intake to combat issues like hypertension and cardiovascular diseases. Government initiatives advocating sodium reduction amplify the demand for salt modulators.
Moreover, these modulators serve as integral components in catering to consumer preferences for healthier food options without compromising on taste, aligning with the prevailing emphasis on balanced diets. The adaptability of salt modulators across diverse food applications, ranging from snacks to processed foods, further solidifies their market dominance. In navigating the landscape of sodium reduction strategies, salt modulators emerge as indispensable, ensuring flavor enhancement while seamlessly aligning with broader consumer health and wellness objectives.
By application, Pharmaceuticals is estimated to grow with the highest CAGR during the forecast period
The escalating demand within the pharmaceutical industry for taste modulators to enhance the palatability of medications, thereby improving patient adherence. This demand is notably pronounced in the development of novel drug formulations. The aging global population, a significant demographic trend, contributes substantially to increased pharmaceutical consumption, creating a robust market for taste modulation in pharmaceuticals.
The imperative to mask the inherently bitter taste of specific medications, particularly crucial in pediatric and geriatric formulations, accentuates the indispensable role of taste modulators. This aligns with the pharmaceutical sector's commitment to patient-centric formulations, making taste modulators a crucial driver for enhanced medication adherence and an improved overall patient experience.
Europe will significantly contribute towards market growth during the forecast period
Europe is poised to play a pivotal role in the growth of the Taste Modulators market throughout the forecast period for several reasons. The region's robust food and beverage industry, coupled with stringent quality and safety standards, positions it as a major contributor. Key players like DSM (Netherlands), Tate & Lyle (UK), Givaudan (Switzerland), and Kerry Group PLC (Ireland) have established a strong presence, leveraging innovations to meet evolving consumer demands.
Stringent regulations and growing consumer awareness regarding the impact of excessive salt, sugar, and fat consumption on health drive the adoption of taste modulators in the region. The European food and beverage industry's commitment to addressing health concerns and delivering products aligned with consumer preferences fuels the integration of taste modulation technologies.